Skandinaviska Enskilda Banken AB (publ) - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 2 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,261
-13.0%
60,5140.0%0.01%
-20.0%
Q2 2023$1,449
+27.2%
60,5140.0%0.01%
+25.0%
Q1 2023$1,139
+12.8%
60,514
-4.7%
0.01%0.0%
Q4 2022$1,010
-99.9%
63,470
-5.5%
0.01%0.0%
Q3 2022$1,099,000
+16.2%
67,1470.0%0.01%
+14.3%
Q2 2022$946,000
-41.8%
67,1470.0%0.01%
-30.0%
Q1 2022$1,626,000
+45.6%
67,147
+41.5%
0.01%
+66.7%
Q4 2021$1,117,000
-25.9%
47,457
-47.7%
0.01%
-25.0%
Q3 2021$1,507,000
-61.0%
90,757
-42.7%
0.01%
-66.7%
Q2 2021$3,862,000
+310.0%
158,357
+333.6%
0.02%
+300.0%
Q1 2021$942,000
-0.8%
36,522
+86.3%
0.01%
-25.0%
Q2 2020$950,00019,6000.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 25,819,768$972,631,0007.89%
SECTORAL ASSET MANAGEMENT INC 822,392$30,980,0003.99%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 240,773$9,068,0003.53%
HARVEY CAPITAL MANAGEMENT INC 230,700$8,690,0003.51%
Palo Alto Investors LP 1,641,030$61,818,0002.60%
GARRISON BRADFORD & ASSOCIATES INC 73,350$2,763,0002.31%
EMORY UNIVERSITY 52,977$1,996,0001.58%
Sivik Global Healthcare LLC 120,000$4,520,0001.54%
Stanley-Laman Group, Ltd. 143,876$5,420,0001.45%
ACUTA CAPITAL PARTNERS, LLC 170,000$6,404,0001.15%
View complete list of ACADIA PHARMACEUTICALS INC shareholders